Matches in SemOpenAlex for { <https://semopenalex.org/work/W4288777617> ?p ?o ?g. }
- W4288777617 endingPage "374" @default.
- W4288777617 startingPage "366" @default.
- W4288777617 abstract "Studies have investigated the effects of androgen deprivation therapy (ADT) use on the incidence and clinical outcomes of coronavirus disease 2019 (COVID-19); however, the results have been inconsistent. We searched the PubMed, Medline, Cochrane, Scopus, and Web of Science databases from inception to March 2022; 13 studies covering 84 003 prostate cancer (PCa) patients with or without ADT met the eligibility criteria and were included in the meta-analysis. We calculated the pooled risk ratios (RRs) with 95% confidence intervals (CIs) to explore the association between ADT use and the infection risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and severity of COVID-19. After synthesizing the evidence, the pooled RR in the SARS-CoV-2 positive group was equal to 1.17, and the SARS-CoV-2 positive risk in PCa patients using ADT was not significantly different from that in those not using ADT ( P = 0.544). Moreover, no significant results concerning the beneficial effect of ADT on the rate of intensive care unit admission (RR = 1.04, P = 0.872) or death risk (RR = 1.23, P = 0.53) were found. However, PCa patients with a history of ADT use had a markedly higher COVID-19 hospitalization rate (RR = 1.31, P = 0.015) than those with no history of ADT use. These findings indicate that ADT use by PCa patients is associated with a high risk of hospitalization during infection with SARS-CoV-2. A large number of high quality studies are needed to confirm these results." @default.
- W4288777617 created "2022-07-30" @default.
- W4288777617 creator A5003654383 @default.
- W4288777617 creator A5015145639 @default.
- W4288777617 creator A5044395307 @default.
- W4288777617 creator A5045481241 @default.
- W4288777617 creator A5053952377 @default.
- W4288777617 creator A5055952802 @default.
- W4288777617 creator A5062756194 @default.
- W4288777617 creator A5072517295 @default.
- W4288777617 creator A5077605724 @default.
- W4288777617 creator A5088807639 @default.
- W4288777617 date "2022-07-29" @default.
- W4288777617 modified "2023-09-26" @default.
- W4288777617 title "Impacts of androgen deprivation therapy on the risks and outcomes of SARS-CoV-2 infection in patients with prostate cancer" @default.
- W4288777617 cites W1247968195 @default.
- W4288777617 cites W1614690294 @default.
- W4288777617 cites W1967758891 @default.
- W4288777617 cites W1968786809 @default.
- W4288777617 cites W1997392820 @default.
- W4288777617 cites W2013602946 @default.
- W4288777617 cites W2030521036 @default.
- W4288777617 cites W2036239678 @default.
- W4288777617 cites W2051767957 @default.
- W4288777617 cites W2051827271 @default.
- W4288777617 cites W2064076043 @default.
- W4288777617 cites W2099037568 @default.
- W4288777617 cites W2101506295 @default.
- W4288777617 cites W2103831745 @default.
- W4288777617 cites W2119504728 @default.
- W4288777617 cites W2119776733 @default.
- W4288777617 cites W2134872401 @default.
- W4288777617 cites W2136403658 @default.
- W4288777617 cites W2140937091 @default.
- W4288777617 cites W2156923287 @default.
- W4288777617 cites W2160956480 @default.
- W4288777617 cites W2169170566 @default.
- W4288777617 cites W2517342767 @default.
- W4288777617 cites W2531269403 @default.
- W4288777617 cites W2740908832 @default.
- W4288777617 cites W2762842166 @default.
- W4288777617 cites W2772636479 @default.
- W4288777617 cites W2801559552 @default.
- W4288777617 cites W2897722618 @default.
- W4288777617 cites W2899587805 @default.
- W4288777617 cites W2902649431 @default.
- W4288777617 cites W2909787042 @default.
- W4288777617 cites W2912991678 @default.
- W4288777617 cites W2979561099 @default.
- W4288777617 cites W2984712394 @default.
- W4288777617 cites W3008827533 @default.
- W4288777617 cites W3009912996 @default.
- W4288777617 cites W3014294089 @default.
- W4288777617 cites W3015403775 @default.
- W4288777617 cites W3016461801 @default.
- W4288777617 cites W3019663170 @default.
- W4288777617 cites W3023316367 @default.
- W4288777617 cites W3023991776 @default.
- W4288777617 cites W3027920451 @default.
- W4288777617 cites W3028311423 @default.
- W4288777617 cites W3033788509 @default.
- W4288777617 cites W3037225065 @default.
- W4288777617 cites W3041171695 @default.
- W4288777617 cites W3042328892 @default.
- W4288777617 cites W3043415123 @default.
- W4288777617 cites W3043720551 @default.
- W4288777617 cites W3049375179 @default.
- W4288777617 cites W3084058347 @default.
- W4288777617 cites W3093211696 @default.
- W4288777617 cites W3093974194 @default.
- W4288777617 cites W3094603252 @default.
- W4288777617 cites W3096548239 @default.
- W4288777617 cites W3120888489 @default.
- W4288777617 cites W3122808906 @default.
- W4288777617 cites W3128271825 @default.
- W4288777617 cites W3129052351 @default.
- W4288777617 cites W3133026883 @default.
- W4288777617 cites W3134994419 @default.
- W4288777617 cites W3135152304 @default.
- W4288777617 cites W3136976888 @default.
- W4288777617 cites W3137692821 @default.
- W4288777617 cites W3153493739 @default.
- W4288777617 cites W3160809780 @default.
- W4288777617 cites W3163192210 @default.
- W4288777617 cites W3165191059 @default.
- W4288777617 cites W3183496668 @default.
- W4288777617 cites W3183895649 @default.
- W4288777617 cites W3190702764 @default.
- W4288777617 cites W3196402595 @default.
- W4288777617 cites W3199127189 @default.
- W4288777617 cites W3201223556 @default.
- W4288777617 cites W3205197323 @default.
- W4288777617 cites W3205868062 @default.
- W4288777617 cites W3210720733 @default.
- W4288777617 cites W3211708924 @default.
- W4288777617 cites W3215306974 @default.
- W4288777617 cites W3217578880 @default.
- W4288777617 cites W4200022103 @default.